K. Gadsby

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

T. Ding, Jo Ledingham, Raashid Luqmani et al. · Lara D. Veeken · 2010 · 215 citations

Medicine, Internal Medicine, Pharmacotherapy +14

Neutropenia in patients receiving anti–tumor necrosis factor therapy

Richard P. Hastings, Tina Ding, K. Gadsby et al. · Arthritis Care & Research · 2010 · 99 citations

Medicine, Immunology, Internal Medicine +17

Anti-TNF-α Agents Are Less Effective for the Treatment of Rheumatoid Arthritis in Current Smokers

Abhishek Abhishek, Sheraz Butt, K. Gadsby et al. · JCR Journal of Clinical Rheumatology · 2009 · 94 citations

Life Sciences, Immunology, Pharmacotherapy +15

Sjogren's Systemic Clinical Activity Index (SCAI) a systemic disease activity measure for use in clinical trials in primary Sjogren's syndrome

Simon Bowman, Nurhan Sutcliffe, David Isenberg et al. · Lara D. Veeken · 2007 · 87 citations · Full text

Medicine, Internal Medicine, Immunopathology +15

The Sjogren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjogren's syndrome

Robert J. Barry, Nurhan Sutcliffe, David Isenberg et al. · Lara D. Veeken · 2008 · 61 citations · Full text

Life Sciences, Immunology, Oral Medicine +17